Antibiotic Resistance and Nanotherapy

Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. Dr. Sharda Bharti is an Assistant Professor in the Department of Biotechnology at the National Institute of Technology (NIT), Raipur, India, an institute of national Importance under the Ministry of Education, Government of India. She completed her MTech and PhD in environmental science and engineering from the Indian Institute of Technology (IIT) Bombay, Mumbai, India. Her research interests primarily focus on the application of nanomaterials in water disinfection, water and wastewater treatment, antimicrobial resistance, and environmental health and safety.

• 1. Introduction to planktonic and biofilm-mediated antimicrobialresistance and role of nanotechnology in overcoming biofilm-mediatedantibiotic resistance2. Key determinants of antimicrobial resistance: exploring the influence ofantibiotic pollution on the emergence of multidrug-resistant microbes3. Drug resistance mechanism in intracellular pathogens and modulation4. Metal-based nanomedicine against intracellular pathogens5. Lipid-based nanomedicine against intracellular pathogens6. Metal-based nanomedicine against extracellular pathogens7. Polymer-based nanomedicine against extracellular pathogens8. Lipid-based nanomedicine against extracellular pathogens9. Interaction between infected host cells and nanodelivery systems10. Innovative strategies utilizing nanoparticles to disrupt c-di-GMP andquorum-sensing signaling pathways to combat antibiotic resistanceinduced by biofilms11. CRISPR-Cas systems for antibiotic resistance12. Synergistic effects of natural compounds and repurposed drugs innanotherapy: a strategy to combat biofilm-associated infections13. Safety, ethical, regulatory issues, and challenges of nanotherapy forantimicrobial resistance